Innate Pharma Balance Sheet (2017-2026)

Reported Financials

Innate Pharma Quarterly Balance Sheet

Periods 16 quarters

Latest Jun 2026

Innate Pharma reported total assets of $39.66M and total liabilities of $85.93M for the quarter ended Jun 2026, down 75.6% year over year. This balance sheet covers 16 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2017	Dec2018	Dec2019	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	118.66M	174.25M	227.28M	147.95M	168.25M	123.76M	117.50M	107.55M	89.79M	77.61M	78.15M	74.95M	69.09M	62.98M	33.00M	7.38M
Short-term InvestmentsInvestments (Current)	19.99M	17.41M	17.90M	18.22M	18.26M	18.26M	18.21M	21.31M	18.40M	18.99M	24.19M	23.35M	14.96M	7.42M	7.30M	5.07M
Cash & Current Investments	138.66M	191.65M	245.18M	166.17M	186.51M	142.01M	135.71M	128.86M	108.19M	96.60M	102.33M	98.30M	84.05M	70.40M	40.30M	12.45M
Receivables - NetNet Receivables	25.57M	174.02M	20.99M	44.31M	26.83M	53.70M	20.86M	64.28M	40.88M	61.35M	61.49M	36.70M	5.17M	19.92M	14.57M	10.09M
Receivables	25.57M	174.02M	20.99M	44.31M	26.83M	53.70M	20.86M	64.28M	40.88M	61.35M	61.49M	36.70M	5.17M	19.92M	14.57M	10.09M
Current Assets	164.22M	365.67M	266.17M	184.10M	213.34M	154.35M	156.58M	179.47M	149.07M	156.99M	163.82M	119.50M	89.22M	76.20M	54.87M	22.39M
Non-Current Assets
Buildings							0.02M
Property, Plant & Equipment (Net)PP&E (Net)	12.81M	12.94M	13.08M	13.98M	14.38M	12.96M	11.52M	9.98M	9.11M	7.90M	7.00M	6.17M	5.34M	5.81M	5.12M	4.16M
Intangibles	55.16M	96.70M	108.63M	107.09M	56.93M	53.79M	50.05M	45.19M	1.66M	0.98M	0.46M	0.13M
Goodwill & Intangibles	55.16M	96.70M	108.63M	107.09M	56.93M	53.79M	50.05M	45.19M	1.66M	0.98M	0.46M	0.13M
Long-Term Deferred Tax		1.79M	1.44M	1.43M	8.72M	6.43M	5.69M	8.13M	9.13M	10.51M	9.97M	9.77M
Other Non-Current Assets	0.13M	0.10M	0.10M	0.16M	0.18M	0.25M	0.17M	0.16M	0.16M	0.09M	0.10M	0.09M	0.60M	0.68M	1.11M	1.00M
Non-Current Assets	140.32M	150.52M	183.44M	190.50M	164.78M	162.49M	146.37M	113.48M	63.39M	59.33M	30.08M	42.73M	26.35M	32.79M	18.81M	17.28M
Assets	304.54M	516.19M	449.62M	374.61M	378.13M	316.85M	302.94M	292.95M	212.46M	216.33M	193.90M	162.23M	115.57M	108.99M	73.68M	39.66M
Liabilities
Current Liabilities
Accounts Payables	29.44M	104.85M	55.46M	29.85M	36.33M	20.26M	32.36M	19.50M	22.29M	20.64M	18.84M	17.00M	16.66M	14.12M	17.67M	12.87M
Payables	29.44M	104.85M	55.46M	29.85M	36.33M	20.26M	32.36M	19.50M	22.29M	20.64M	18.84M	17.00M	16.66M	14.12M	17.67M	12.87M
Short term Debt	1.21M	0.04M	0.16M	0.29M	0.83M	6.69M	0.73M	0.82M	1.64M	1.91M	0.67M	0.40M	0.29M	1.30M	4.09M	1.91M
Current Taxes		24.01M	23.87M	13.51M	55.17M	45.76M	37.37M	61.59M	56.49M	53.82M	49.84M	44.87M	42.80M	40.48M	37.30M	34.97M
Current Deferred Revenue	161.11M	171.82M	99.83M	69.81M	54.09M	45.31M	14.16M	9.50M	6.99M	5.49M	6.49M	3.00M	0.64M	0.66M	3.32M	0.15M
Total Current Liabilities	88.26M	225.07M	136.47M	92.62M	55.95M	50.72M	90.47M	76.85M	44.07M	40.94M	43.87M	40.93M	34.32M	34.51M	43.05M	37.53M
Non-Current Liabilities
Non-Current Debt	5.40M	3.63M	18.59M	18.87M	20.84M	17.24M	15.29M	13.08M	42.80M	38.39M	34.26M	28.46M	23.19M	21.22M	16.18M	10.75M
Non-Current Deffered Revenue	103.90M	77.90M	45.19M	23.05M	40.19M	32.85M	28.78M	8.71M	8.44M	6.49M	5.11M	4.41M	2.94M	3.08M
Pension	3.13M	4.23M	4.21M	4.67M	5.14M	4.62M	3.37M	2.82M	2.72M	2.75M	2.70M	2.64M	2.84M	3.13M	2.26M	2.23M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax		1.79M	1.44M	1.43M	8.72M	6.43M	5.69M	8.13M	9.13M	10.51M	9.97M	9.77M
Total Non-Current Liabilities	113.64M	99.80M	69.59M	48.32M	130.33M	107.16M	90.79M	94.58M	110.67M	112.50M	92.59M	90.46M	72.06M	68.45M	56.12M	48.40M
Total Liabilities	201.90M	324.87M	206.06M	140.93M	186.28M	157.89M	181.26M	171.43M	154.73M	153.44M	136.46M	131.39M	106.38M	102.96M	99.17M	85.93M
Shareholder's Equity
Total Debt	6.61M	3.68M	18.75M	19.17M	21.67M	23.93M	16.02M	13.90M	44.45M	40.29M	34.93M	28.86M	23.48M	22.52M	20.26M	12.67M
Common Equity	102.65M	191.32M	243.56M	233.68M	191.85M	158.96M	121.68M	121.53M	57.73M	62.89M	57.45M	30.84M	9.19M	6.03M	-25.50M	-46.27M
Liabilities and Shareholders Equity	304.54M	516.19M	449.62M	374.61M	378.13M	316.85M	302.94M	292.95M	212.46M	216.33M	193.90M	162.23M	115.57M	108.99M	73.68M	39.66M
Retained Earnings	-123.71M	-158.95M	-151.13M	-175.14M	-192.46M	-262.36M	-248.48M	-284.40M	-290.20M	-358.99M	-364.50M	-360.76M	-350.58M	-453.11M	-453.87M	-497.48M

Innate Pharma Balance Sheet API

Pull Innate Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IPHA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "IPHA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=IPHA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Innate Pharma IPHA Balance Sheet (2017-2026)

Innate Pharma Quarterly Balance Sheet

Innate Pharma Balance Sheet API

Create an account

Sign In

Reset Password